LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)
Dead / Abandoned — Abandoned — failure to respond (as of 22 Nov 2020)
What this means for you
This application is over — abandoned 09 Nov 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88281416
- Mark type
- Stylized text
- Filed
- 29 Jan 2019
- Published for opposition
- 11 Jun 2019
- Abandoned
- 09 Nov 2020
- Attorney of record
- Sean MacKenzie
Goods and services
- Class 005 — Pharmaceuticals: Transdermally delivered pharmaceutical preparations for the treatment of joint and muscle pain conditions
Owner
- Nexzol Pharma, Inc., San Clemente, CA, US
- Nexzol Pharma, Inc., San Clemente, CA, US
Prosecution history
- 23 Nov 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 22 Nov 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 06 May 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 May 2020 — NON-FINAL ACTION E-MAILED
- 06 May 2020 — SU - NON-FINAL ACTION - WRITTEN
- 01 Apr 2020 — ASSIGNED TO EXAMINER
- 30 Dec 2019 — ASSIGNED TO EXAMINER
- 20 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Dec 2019 — USE AMENDMENT FILED
- 20 Dec 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 06 Aug 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jun 2019 — PUBLISHED FOR OPPOSITION
- 22 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED